Pharmacogenetics of breast cancer : towards the individualization of therapy / / edited by Brian Leyland-Jones |
Pubbl/distr/stampa | New York : , : CRC Press, , 2008 |
Descrizione fisica | 1 online resource (352 p.) |
Disciplina | 616.99449061 |
Altri autori (Persone) | Leyland-JonesBrian |
Collana | Translational medicine series |
Soggetto topico |
Breast - Cancer - Genetic aspects
Breast - Cancer - Chemotherapy Pharmacogenetics |
ISBN |
0-429-52568-0
0-429-13772-9 1-281-73192-7 9786611731922 1-4200-5294-2 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Front Cover; Preface; Acknowledgments; Contents; Chapter 1; Chapter 2; Chapter 3; Chapter 4; Chapter 5; Chapter 6; Chapter 7; Chapter 8; Chapter 9; Chapter 10; Chapter 11; Chapter 12; Chapter 13; Chapter 14; Chapter 15; Chapter 16; Chapter 17; Chapter 18; Chapter 19; Chapter 20; Index; Back Cover; |
Record Nr. | UNINA-9910782137603321 |
New York : , : CRC Press, , 2008 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Pharmacogenetics of breast cancer : towards the individualization of therapy / / edited by Brian Leyland-Jones |
Edizione | [1st ed.] |
Pubbl/distr/stampa | New York, : Informa Healthcare USA, c2008 |
Descrizione fisica | 1 online resource (352 p.) |
Disciplina | 616.99449061 |
Altri autori (Persone) | Leyland-JonesBrian |
Collana | Translational medicine series |
Soggetto topico |
Breast - Cancer - Genetic aspects
Breast - Cancer - Chemotherapy Pharmacogenetics |
ISBN |
0-429-52568-0
0-429-13772-9 1-281-73192-7 9786611731922 1-4200-5294-2 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Front Cover; Preface; Acknowledgments; Contents; Chapter 1; Chapter 2; Chapter 3; Chapter 4; Chapter 5; Chapter 6; Chapter 7; Chapter 8; Chapter 9; Chapter 10; Chapter 11; Chapter 12; Chapter 13; Chapter 14; Chapter 15; Chapter 16; Chapter 17; Chapter 18; Chapter 19; Chapter 20; Index; Back Cover; |
Record Nr. | UNINA-9910824286803321 |
New York, : Informa Healthcare USA, c2008 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
PI3K-mTOR in Cancer and Cancer Therapy / / edited by Nandini Dey, Pradip De, Brian Leyland-Jones |
Edizione | [1st ed. 2016.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Humana, , 2016 |
Descrizione fisica | 1 online resource (XXIV, 294 p. 31 illus. in color.) |
Disciplina | 616.994071 |
Collana | Cancer Drug Discovery and Development |
Soggetto topico |
Cancer - Research
Molecular biology Drug resistance Cancer Research Molecular Medicine Drug Resistance |
ISBN | 3-319-34211-8 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | PI3K-Akt-mTOR Signaling in Cancer and Cancer Therapeutics -- Part 1: PI3K-mTOR Pathway in Cancers -- The mTOR Complexes in Cancer Cell Metabolism -- PI3K-AKT-mTOR Pathway Co-operates with the DNA Damage Repair Pathway: Carcinogenesis in Triple Negative Breast Cancers and Beyond -- The AKT-mTOR Signaling Pathway for Drug Response Prediction and Prognostic Signatures -- Resistance to PI3K Pathway Inhibition -- Part 2: PI3K-mTOR Pathway in Cancer Medicine -- Combination Therapies Targeting the PI3K/AKT/mTOR Pathways -- Phospho-Inositol-3-Kinase Activity and Dysregulation in Pediatric Leukemia and Lymphoma -- HER2 Signaling Network in Advanced Breast Cancer: Opportunities for Combination Therapies -- The PI3K-mTOR Pathway in Prostate Cancer: Biological Significance and Therapeutic Opportunities. |
Record Nr. | UNINA-9910254558503321 |
Cham : , : Springer International Publishing : , : Imprint : Humana, , 2016 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|